Evidence map›Paper›PMID 22257369›Full record

ArticleGenes, brain, and behavior2012

The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.

M F Vinueza Veloz, R A M Buijsen, R Willemsen, A Cupido, L W J Bosman, S K E Koekkoek, J W Potters, B A Oostra, C I De Zeeuw

Open access · greenAbstract read
In one paragraph

Article in Genes, brain, and behavior, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Deletion of the voltage-gated calcium channel, CaGenes, brain, and behavior · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Inducible expression of humanDisease models & mechanisms · 2021
    Article
  9. Rethinking Intellectual Disability from Neuro- to Astro-Pathology.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Of Men and Mice: Modeling the Fragile X Syndrome.Frontiers in molecular neuroscience · 2018
    Article
  16. Ablation of TFR1 in Purkinje Cells Inhibits mGlu1 Trafficking and Impairs Motor Coordination, But Not Autistic-Like Behaviors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  17. Article
  18. RNA-binding profiles ofProceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

M F Vinueza VelozDepartment of Neuroscience, Erasmus Medical Center, Rotterdam Netherlands.
R A M Buijsen
R Willemsen
A Cupido
L W J Bosman
S K E Koekkoek
J W Potters
B A Oostra
C I De Zeeuw
Erasmus MC · NLNetherlands Institute for Neuroscience · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fragile X syndrome (FXS) is the most common inherited form of intellectual disability. Patients with FXS do not only suffer from cognitive problems, but also from abnormalities/deficits in procedural memory formation. It has been proposed that a lack of fragile X mental retardation protein (FMRP) leads to altered long-term plasticity by deregulation of various translational processes at the synapses, and that part of these impairments might be rescued by the inhibition of type I metabotropic glutamate receptors (mGluRs). We recently developed the Erasmus Ladder, which allows us to test, without any invasive approaches, simultaneously, both procedural memory formation and avoidance behavior during unperturbed and perturbed locomotion in mice. Here, we investigated the impact of a potent and selective mGluR5 inhibitor (Fenobam) on the behavior of Fmr1 KO mice during the Erasmus Ladder task. Fmr1 KO mice showed deficits in associative motor learning as well as avoidance behavior, both of which were rescued by intraperitoneal administration of Fenobam. While the Fmr1 KO mice did benefit from the treatment, control littermates suffered from a significant negative side effect in that their motor learning skills, but not their avoidance behavior, were significantly affected. On the basis of these studies in the FXS animal model, it may be worthwhile to investigate the effects of mGluR inhibitors on both the cognitive functions and procedural skills in FXS patients. However, the use of mGluR inhibitors appears to be strongly contraindicated in healthy controls or non-FXS patients with intellectual disability.

Indexed as

AnimalsAvoidance LearningCognition DisordersDiscrimination LearningDisease Models, AnimalExcitatory Amino Acid AntagonistsFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeImidazolesMemory DisordersMiceMice, Inbred C57BLMice, KnockoutReceptor, Metabotropic Glutamate 5Receptors, Metabotropic GlutamateExcitatory Amino Acid AntagonistsfenobamFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Grm5 protein, mouseImidazolesReceptor, Metabotropic Glutamate 5Receptors, Metabotropic Glutamate

Identifiers

PMID22257369
PMCPMC3491868
OpenAlexW2001996712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.